Serveur d'exploration Tocilizumab - Curation (Istex)

Index « Pays » - entrée « Portugal »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pologne < Portugal < Pérou  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000075 (2011) J. D. Alves [Portugal] ; A. Marinho [Portugal] ; M. J. Serra [Portugal]Tocilizumab: is there life beyond anti‐TNF blockade?
000189 (2013) Diogo Mendes [Portugal] ; Carlos Alves [Portugal] ; Francisco Batel Marques [Portugal]Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events
000427 (2010) I. Perpétuo ; D. Fernandes ; R. Cascão ; R. Moura ; J. Caetano-Lopes ; A. Rodrigues [Portugal] ; J. Polido-Pereira [Portugal] ; M. Viana Queiroz [Portugal] ; J E Fonseca [Portugal] ; H. Canhão [Portugal]Tumour necrosis factor antagonists and tocilizumab have a higher impact on rheumatoid arthritis osteoclastogenic stimuli than methotrexate
000435 (2010) I. Perpétuo ; J. Caetano-Lopes ; A. Rodrigues [Portugal] ; J. Polido-Pereira [Portugal] ; M Viana Queiroz [Portugal] ; J E Fonseca [Portugal] ; H. Canhão [Portugal]Influence of anti-tumour necrosis factor drugs, tocilizumab and methotrexate on osteoclast differentiation
000446 (2013) Vasco C. Romão [Portugal] ; Maria José Santos [Portugal] ; José Canas Da Silva [Portugal] ; Joaquim Polido Pereira [Portugal] ; José Alberto Pereira Da Silva [Portugal] ; Cátia Duarte [Portugal] ; José Ant Nio Pereira Da Silva [Portugal] ; Cândida Silva [Portugal] ; Ana Assunção Teixeira [Portugal] ; José Antonio Costa [Portugal] ; Domingos Araújo [Portugal] ; Fernando Pimentel Santos [Portugal] ; Jaime Branco [Portugal] ; José Ant Nio Melo Gomes [Portugal] ; Augusto Faustino [Portugal] ; João Eurico Fonseca [Portugal] ; Helena Canhão [Portugal]A10.5 Comparative Effectiveness of Biological Therapies in Rheumatoid Arthritis is Influenced by Response Measures and Disease Activity State
000497 (2011) Raquel Roque [Portugal] ; Sofia Ramiro [Portugal] ; Ana Cordeiro [Portugal] ; Pedro Gonçalves [Portugal] ; Silva Da Canas [Portugal] ; Maria J. Santos [Portugal]Development of amyloidosis in patients with rheumatoid arthritis under TNF-blocking agents
000505 (2013) J. F. Ferreira [Portugal] ; M. G. Santiago [Portugal] ; C. Duarte [Portugal] ; J. A. P. Da Silva [Portugal]AB0315 Is the efficacy of biologic therapeutic in rheumatoid arthritis is affected by body mass index?
000537 (2012) Rita A. Moura [Portugal] ; Luis Graca [Portugal] ; João E. Fonseca [Portugal]To B or Not to B the Conductor of Rheumatoid Arthritis Orchestra
000627 (2013) R. Marques ; F. Ramos ; I. Perpétuo ; S. Fernandes ; A. C. Furtado ; A. F. Mourão ; F. Martins [Portugal] ; J. E. Fonseca ; J. A. Pereira Da SilvaAB0696 Predictors of poor response to 6-months methotrexate therapy in a juvenile idiopathic arthritis cohort of patients
000735 (2013) A. Raposo [Portugal] ; D. Peixoto [Portugal] ; F. Teixeira [Portugal] ; M. Cerqueira [Portugal] ; M. Bogas [Portugal] ; J. Costa [Portugal] ; C. Afonso [Portugal] ; D. Araújo [Portugal]THU0446 Evaluation of Fatigue in Patients with Spondyloarthritis
000925 (2012) P. A. Laires [Portugal] ; F. Exposto [Portugal] ; R. Mesquita [Portugal] ; A. P. Martins [Portugal] ; L. Cunha-Miranda [Portugal] ; J. E. Fonseca [Portugal]Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries
000990 (2014) Juliana Nunes Avila [Portugal] ; Susana Bonacho Carvalho [Portugal] ; Graça Tavares [Portugal] ; Ruben Garcia [Portugal]Fever of unknown origin in a patient with red ears: relapsing polychondritis
000A00 (2013) C. Ponte A. Castro [Portugal] ; C. Macieira ; C. Miranda Rosa ; J. A. Pereira Da SilvaTHU0385 Cogan syndrome: A portuguese single center cohort report
000A48 (2010) Maria José Santos [Portugal] ; Diana Fernandes [Portugal] ; Susana Capela [Portugal] ; Jose Canas Da Silva [Portugal] ; João Eurico Fonseca [Portugal]Interleukin-6 promoter polymorphism −174 G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients
000B51 (2013) M. Gutierrez ; L. Di Geso [Italie] ; J. Rovisco [Portugal] ; M. Di Carlo ; A. Ariani [Italie] ; E. Filippucci ; W. GrassiSAT0504 Ultrasound Learning Curve in Gout: a Disease-Oriented Training Programme
000B68 (2013) A. A. Marques [Portugal] ; R. Ferreira [Portugal] ; T. Santiago [Portugal]THU0459-HPR Anxiety and depression scores reduction after six-months of biology therapy
000B77 (2013) A. M. Castro ; D. C. Fernandes ; M. J. Santos ; L. Mendes-Pedro [Portugal] ; H. Canhão ; J. E. Fonseca ; J. A. Pereira Da SilvaAB0202 Ultrasonografic carotid plaque morphology in women with rheumatoid arthritis without previous cardiovascular events
000D27 (2016) A. Gameiro [Portugal] ; M. Gouveia [Portugal] ; M. Pereira [Portugal] ; O. Tellechea [Portugal] ; M. Gonçalo [Portugal]Clinical characterization and long‐term follow‐up of Schnitzler syndrome
000D71 (2013) D. Peixoto [Portugal] ; F. Teixeira [Portugal] ; A. Raposo [Portugal] ; J. Costa [Portugal] ; M. Bogas [Portugal] ; C. Afonso [Portugal] ; D. Araújo [Portugal]AB0802 Beliefs and treatment satisfaction in patients receiving biological agents
000D88 (2013) V. C. Romão [Portugal] ; M. J. Saavedra [Portugal] ; E. Vieira-Sousa [Portugal] ; M. Costa [Portugal] ; J. Polido-Pereira [Portugal] ; A. M. Rodrigues [Portugal] ; F. Ramos [Portugal] ; C. Macieira [Portugal] ; S. Capela [Portugal] ; C. Resende [Portugal] ; J. Madruga Dias [Portugal] ; C. Ponte [Portugal] ; R. Campanilho-Marques [Portugal] ; A. Castro [Portugal] ; C. Furtado [Portugal] ; S. Fernandes [Portugal] ; M. J. Gonçalves [Portugal] ; J. A. Pereira Da Silva [Portugal] ; H. Canhão [Portugal] ; J. E. Fonseca [Portugal]AB0293 Can we safely start biological therapy in rheumatic patients with prior history of active tuberculosis?
000F47 (2013) S. Garcês ; J. Demengeot ; E. Benito-Garcia [Portugal]SAT0479 Clinical impact of immunogenicity of infliximab, adalimumab and etanercept: A systematic review of the literature with a meta-analysis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AffPays.i -k "Portugal" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AffPays.i  \
                -Sk "Portugal" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Portugal
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021